Search
 
Best Practices

When There's No Choice But to Work

For anti-viral drug maker Roche, business continuity planning is a mission

By Anne Field | Updated on May 01, 2007

Three years ago, Hoffmann-La Roche CEO and president George Abercrombie began to think seriously about what would happen if his company was unable to maintain operations in the case of a flu pandemic. As the only producer of Tamiflu, an anti-viral drug that helps treat flu symptoms, the inability of the Nutley, N.J.-based drug maker to conduct some semblance of business as usual would have dire consequences not only for Roche’s financials–it could also jeopardize the world’s ability to combat the outbreak. In fact, given the circumstances, Abercrombie realized his company would need not only to continue manufacturing, but Roche would have to run at top speed.

Not every company has a life or death mission to accomplish like Roche, but many face a similar reality. Experts agree that a flu pandemic of some kind carries a high probability–some call it inevitable. And, with predictions that the flu could kill 2.25 million people and force 87.75 million employees to miss work for three weeks, the question of just how to keep operations running is one likely to confront most companies at some point in the not so distant future.

Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.

Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.

Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Recommended Stories

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2024 ALM Global, LLC. All Rights Reserved.